Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in AUVA Trauma Research Center, Vienna, Austria.
Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Adv Exp Med Biol. 2018;1077:3-17. doi: 10.1007/978-981-13-0947-2_1.
Laminins are major components of all basement membranes surrounding nerve or vascular tissues. In particular laminin-111, the prototype of the family, facilitates a large spectrum of fundamental cellular responses in all eukaryotic cells. Laminin-111 is a biomaterial frequently used in research, however it is primarily isolated from non-human origin or produced with time-intensive recombinant techniques at low yield.Here, we describe an effective method for isolating laminin-111 from human placenta, a clinical waste material, for various tissue engineering applications. By extraction with Tris-NaCl buffer combined with non-protein-denaturation ammonium sulfate precipitation and rapid tangential flow filtration steps, we could effectively isolate native laminin-111 within only 4 days. The resulting material was biochemically characterized using a combination of dot blot, SDS-PAGE, Western blot and HPLC-based amino acid analysis. Cytocompatibility studies demonstrated that the isolated laminin-111 promotes rapid and efficient adhesion of primary Schwann cells. In addition, the bioactivity of the isolated laminin-111 was demonstrated by (a) using the material as a substrate for outgrowth of NG 108-15 neuronal cell lines and (b) promoting the formation of interconnected vascular networks by GFP-expressing human umbilical vein endothelial cells.In summary, the isolation procedure of laminin-111 as described here from human placenta tissue, fulfills many demands for various tissue engineering and regenerative medicine approaches and therefore may represent a human alternative to various classically used xenogenic standard materials.
层粘连蛋白是围绕神经或血管组织的所有基底膜的主要成分。特别是层粘连蛋白-111,是该家族的原型,促进了所有真核细胞中大量基本的细胞反应。层粘连蛋白-111是一种在研究中经常使用的生物材料,但是它主要是从非人类来源分离得到的,或者是通过耗时的重组技术以低产量生产得到的。在这里,我们描述了一种从人胎盘(一种临床废物)中分离层粘连蛋白-111的有效方法,用于各种组织工程应用。通过 Tris-NaCl 缓冲液提取,结合非变性硫酸铵沉淀和快速切向流过滤步骤,我们可以在短短 4 天内有效地分离出天然的层粘连蛋白-111。通过点印迹、SDS-PAGE、Western blot 和基于 HPLC 的氨基酸分析的组合,对得到的材料进行了生物化学表征。细胞相容性研究表明,分离出的层粘连蛋白-111促进了原代施万细胞的快速和有效的粘附。此外,分离出的层粘连蛋白-111 的生物活性通过以下方式得到证明:(a)将该材料用作 NG 108-15 神经元细胞系生长的基质,和(b)促进 GFP 表达的人脐静脉内皮细胞形成相互连接的血管网络。总之,这里从人胎盘组织中描述的层粘连蛋白-111 的分离程序满足了各种组织工程和再生医学方法的许多需求,因此可能代表了各种经典使用的异种标准材料的人类替代品。